Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

DBV Technologies SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

30 Apr 2016 Reuters Investment Profile 12 $20.00

DBV TECHNOLOGIES SA (DBVT=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

23 Apr 2016 Pechala's Reports 2 $25.00

DBV Technologies S.A. (DBV) - Financial Analysis Review

DBV Technologies S.A. (DBV) - Financial Analysis Review Summary DBV Technologies S.A. (DBV) is a biopharmaceutical company th...

19 Apr 2016 GlobalData 56 $300.00

Wright Investors Service Comprehensive Report for Dbv Technologies

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

03 Apr 2016 Wright Reports 55 $75.00

DBV.PA - Event Transcript of DBV Technologies SA conference call, Mar. 16, 2016 / 2:35PM ET

Edited Event Transcript of DBV.PA conference call, Mar. 16, 2016 / 2:35PM ET Miami, Mar 16, 2016 (Thomson StreetEvents)...

16 Mar 2016 Thomson Reuters StreetEvents 7 $75.00

DBV Technologies S.A. (DBV) - Financial Analysis Review

DBV Technologies S.A. (DBV) - Financial Analysis Review Summary DBV Technologies S.A. (DBV) is a biopharmaceutical company th...

16 Mar 2016 GlobalData 55 $300.00

DBV.PA - Event Transcript of DBV Technologies SA conference call, Mar. 06, 2016 / 9:30PM ET

Edited Event Transcript of DBV.PA conference call, Mar. 06, 2016 / 9:30PM ET Los Angeles, Mar 9, 2016 (Thomson StreetEv...

06 Mar 2016 Thomson Reuters StreetEvents 21 $75.00

DBV TECHNOLOGIES SA - TERMINATION OF COVERAGE

Edison Investment Research is terminating coverage on DBV Technologies SA (DBV). Please note you should no longer rely on any...

01 Feb 2016 Edison Investment Research 1 $10.00

DBV TECHNOLOGIES: ADR UPDATE - ENLARGED PHASE III PEPITES STUDY STARTS

DBV has now started the Phase III Viaskin Peanut trial (PEPITES), which has been enlarged to meet patient and investigator de...

09 Dec 2015 Edison Investment Research 5 $10.00

DBV TECHNOLOGIES - ENLARGED PHASE III PEPITES STUDY STARTS

DBV has now started the Phase III Viaskin Peanut trial (PEPITES), which has been enlarged to meet patient and investigator de...

09 Dec 2015 Edison Investment Research 5 $10.00